We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Boron Radiotherapy May Cure Human Cancers

By HospiMedica International staff writers
Posted on 17 Apr 2013
Scientists have recently developed a new type of radiation therapy that effectively pushes cancer into remission in lab mice. More...
Significantly, this cutting-edge radiotherapy generated none of the destructive side effects of traditional chemo and radiation cancer therapies.

Clinical trials in humans could begin soon after the investigators secure funding. “Since the 1930s, scientists have sought success with a cancer treatment known as boron neutron capture therapy [BNCT],” said University of Missouri’s (MU; Columbia, USA) Prof. M. Frederick Hawthorne, a recent winner of the US National Medal of Science awarded by President Obama. “Our team at MU’s International Institute of Nano and Molecular Medicine finally found the way to make BNCT work by taking advantage of a cancer cell’s biology with nanochemistry.”

Cancer cells grow faster than healthy cells and in so doing, absorb more substances than normal cells. Prof. Hawthorne’s team exploited that fact by getting cancer cells to capture and store a boron chemical designed by Prof. Hawthorne. When boron-infused cancer cells were exposed to neutrons, the boron atom shattered and selectively ripped apart the cancer cells, sparing surrounding healthy cells.

The physical features of boron made Prof. Hawthorne’s technique possible. A specific form of boron will split when it captures a neutron and release lithium, helium, and energy. Similar to pool balls zigzagging around a billiards table, the lithium and helium atoms penetrate the cancer cell and destroy it from the inside without harming the neighboring tissues.

“A wide variety of cancers can be attacked with our BNCT technique,” Prof. Hawthorne said. “The technique worked excellently in mice. We are ready to move on to trials in larger animals, then people. However, before we can start treating humans, we will need to build suitable equipment and facilities. When it is built, MU will have the first radiation therapy of this kind in the world.”

The study’s findings were published ahead of print on March 27, 2013, in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS).

Related Links:

University of Missouri



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Electrode Solution and Skin Prep
Signaspray
Pulmonary Ventilator
OXYMAG
Digital X-Ray Detector Panel
Acuity G4
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.